A nasal spray technology which promises an alternative drug delivery method for biologic drugs has been given a funding boost.
Critical Pharmaceuticals, a spin-out company from The University of Nottingham, has secured a £1.5 million translation award from the Wellcome Trust to develop the nasal spray to deliver Human Growth Hormone (hGH).
Large molecule biological drugs are playing an increasingly important role in medicine, but usually require an injection to administer them, which are disliked and inconvenient for patients.
The company is focusing on hGH as the first drug to be delivered using the system.
Pharmafocus.com
Critical Pharmaceuticals, a spin-out company from The University of Nottingham, has secured a £1.5 million translation award from the Wellcome Trust to develop the nasal spray to deliver Human Growth Hormone (hGH).
Large molecule biological drugs are playing an increasingly important role in medicine, but usually require an injection to administer them, which are disliked and inconvenient for patients.
The company is focusing on hGH as the first drug to be delivered using the system.
Pharmafocus.com
